Anaemia is an independent predictor of poor outcome in patients with chronic heart failure
- 1 August 2003
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 90 (2-3) , 303-308
- https://doi.org/10.1016/s0167-5273(02)00574-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Morbidity and Mortality Reduction Associated with the Use of ErythropoietinNephron, 2000
- Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicityAmerican Heart Journal, 1999
- The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseasePublished by Elsevier ,1996
- Renal Anaemia Treatment with Recombinant Human Erythropoietin Increases Cardiac Output in Patients with Ischaemic Heart DiseaseScandinavian Journal of Urology and Nephrology, 1996
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-upAmerican Heart Journal, 1994
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- The Erythrocyte Sedimentation Rate in Congestive Heart FailureNew England Journal of Medicine, 1991